Literature DB >> 2035565

Cocaine and the use of alcohol and other drugs during pregnancy.

A P Streissguth1, T M Grant, H M Barr, Z A Brown, J C Martin, D E Mayock, S L Ramey, L Moore.   

Abstract

Recent reports of adverse pregnancy outcomes associated with prenatal cocaine exposure have raised questions about the actual numbers of infants who are exposed to cocaine in utero. Whereas toxicologic urine screens obtained at delivery can detect cocaine use in the preceding few days, they fail to yield a comprehensive picture of use during and immediately before pregnancy. According to postpartum self-report, 15% of a teaching hospital sample and 3% of a private hospital sample of mothers had used cocaine during pregnancy or in the previous month (total = 876). Rates at the teaching hospital reflect a fifteenfold increase over the past 12-year period, when compared with previously obtained data. Cocaine users were significantly more likely to report that they drank alcohol, smoked cigarettes, and took other illicit drugs during pregnancy than women who denied using cocaine. Mothers at highest risk for cocaine use were those who were black (20%), were single-separated-divorced (24% to 33%), and had less than a high school education (21%).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035565     DOI: 10.1016/0002-9378(91)90691-j

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

2.  Cocaine binding sites in fetal rat brain: implications for prenatal cocaine action.

Authors:  J S Meyer; L P Shearman; L M Collins; R L Maguire
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse.

Authors:  J L Murphy
Journal:  Can J Anaesth       Date:  1993-02       Impact factor: 5.063

Review 4.  Neurodevelopmental effects of cocaine.

Authors:  L Singer; R Arendt; S Minnes
Journal:  Clin Perinatol       Date:  1993-03       Impact factor: 3.430

5.  Illicit drug use and adverse birth outcomes: is it drugs or context?

Authors:  Ashley H Schempf; Donna M Strobino
Journal:  J Urban Health       Date:  2008-09-15       Impact factor: 3.671

6.  Risk-taking and the feedback negativity response to loss among at-risk adolescents.

Authors:  Michael J Crowley; Jia Wu; Clifford Crutcher; Christopher A Bailey; C W Lejuez; Linda C Mayes
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

7.  Fetal Growth Outcomes in a Cohort of Polydrug- and Opioid-Dependent Patients.

Authors:  Laura Garrison; Lawrence Leeman; Renate D Savich; Hilda Gutierrez; William F Rayburn; Ludmila N Bakhireva
Journal:  J Reprod Med       Date:  2016 Jul-Aug       Impact factor: 0.142

8.  Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.

Authors:  Dana Serino Ma; Bradley S Peterson Md; Tove S Rosen Md
Journal:  J Dual Diagn       Date:  2018-09-05

9.  Alcohol use before and during pregnancy in western Washington, 1989-2004: implications for the prevention of fetal alcohol spectrum disorders.

Authors:  Therese M Grant; Janet E Huggins; Paul D Sampson; Cara C Ernst; Helen M Barr; Ann P Streissguth
Journal:  Am J Obstet Gynecol       Date:  2008-11-22       Impact factor: 8.661

Review 10.  Universal alcohol/drug screening in prenatal care: a strategy for reducing racial disparities? Questioning the assumptions.

Authors:  Sarah C M Roberts; Amani Nuru-Jeter
Journal:  Matern Child Health J       Date:  2011-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.